• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来西亚成年人血脂异常亚型及其相关个人和临床特征的高患病率:REDISCOVER 研究。

High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study.

机构信息

Department of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selayang Campus, Jalan Prima Selayang 7, 68100, Batu Caves, Selangor, Malaysia.

Department of Community Medicine, School of Medicine, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.

出版信息

BMC Cardiovasc Disord. 2021 Mar 23;21(1):149. doi: 10.1186/s12872-021-01956-0.

DOI:10.1186/s12872-021-01956-0
PMID:33757445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7988996/
Abstract

BACKGROUND

Dyslipidaemia refers to lipid abnormalities consisting of either one or any combination of the following: elevated total cholesterol (TC), elevated low-density lipoprotein cholesterol (LDL-c), elevated triglycerides (TG), and low high-density lipoprotein cholesterol (HDL-c). The prevalence of hypercholesterolaemia is steadily increasing in Malaysia. However, data on the prevalence of dyslipidaemia subtypes among Malaysians are lacking. This is important as it may have implications for preventive and management strategies for this increasing public health challenge. This study is aimed at determining the prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysians.

METHODS

REDISCOVER, a prospective study, enrolled 11,288 adults where sociodemographic data, anthropometric and blood pressure measurements, fasting lipid profile and glucose, and history of diabetes, hypertension, and smoking were obtained. The cross-sectional analytic sample presented in this article comprised 10,482 participants from baseline recruitment. The data was analysed by descriptive statistics and multivariable logistic regression.

RESULTS

The overall prevalence of elevated TC, elevated LDL-c, elevated TG, low HDL-c, and elevated non-HDL-c were 64.0% (95% CI 63.0-65.0), 56.7% (CI 55.7-57.7), 37.4% (CI 36.5-38.4), 36.2% (CI 35.2-37.1), and 56.2% (CI 55.3-57.2), respectively. Overweight, obesity, and central obesity were highly prevalent and significantly associated with elevated TC and all dyslipidaemia subtypes. Older age was associated with elevated TC, elevated LDL-c and elevated non-HDL-c. Hypertension was associated with elevated TC, elevated TG, and elevated non-HDL-c, while diabetes was associated with elevated TG and low HDL-c.

CONCLUSIONS

Elevated TC and all dyslipidaemia subtypes are highly prevalent in Malaysia where increased body mass seems the main driver. Differences in the prevalence and associated personal and clinical attributes may facilitate specific preventive and management strategies.

摘要

背景

血脂异常是指一种或多种以下脂质异常:总胆固醇(TC)升高、低密度脂蛋白胆固醇(LDL-c)升高、甘油三酯(TG)升高和高密度脂蛋白胆固醇(HDL-c)降低。马来西亚的高胆固醇血症患病率稳步上升。然而,缺乏马来西亚人血脂异常亚型患病率的数据。这一点很重要,因为它可能对这一日益严重的公共卫生挑战的预防和管理策略产生影响。本研究旨在确定血脂异常亚型的患病率及其在马来西亚人中的相关个人和临床特征。

方法

RECOVER 是一项前瞻性研究,共纳入 11288 名成年人,获取社会人口统计学数据、人体测量学和血压测量、空腹血脂和血糖以及糖尿病、高血压和吸烟史。本文呈现的横断面分析样本由基线招募的 10482 名参与者组成。通过描述性统计和多变量逻辑回归分析数据。

结果

TC 升高、LDL-c 升高、TG 升高、HDL-c 降低和非 HDL-c 升高的总体患病率分别为 64.0%(95%CI 63.0-65.0)、56.7%(CI 55.7-57.7)、37.4%(CI 36.5-38.4)、36.2%(CI 35.2-37.1)和 56.2%(CI 55.3-57.2)。超重、肥胖和中心性肥胖非常普遍,与 TC 升高和所有血脂异常亚型显著相关。年龄较大与 TC、LDL-c 和非 HDL-c 升高相关。高血压与 TC、TG 和非 HDL-c 升高相关,而糖尿病与 TG 和 HDL-c 降低相关。

结论

TC 升高和所有血脂异常亚型在马来西亚都非常普遍,体重增加似乎是主要驱动因素。患病率和相关个人及临床特征的差异可能有助于制定特定的预防和管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/7988996/35533c8adc8b/12872_2021_1956_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/7988996/a7c562e5d016/12872_2021_1956_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/7988996/35533c8adc8b/12872_2021_1956_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/7988996/a7c562e5d016/12872_2021_1956_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/7988996/35533c8adc8b/12872_2021_1956_Fig2_HTML.jpg

相似文献

1
High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study.马来西亚成年人血脂异常亚型及其相关个人和临床特征的高患病率:REDISCOVER 研究。
BMC Cardiovasc Disord. 2021 Mar 23;21(1):149. doi: 10.1186/s12872-021-01956-0.
2
Evaluation of Dyslipidaemia Using an Algorithm of Lipid Profile Measures among Newly Diagnosed Type II Diabetes Mellitus Patients: A Cross-Sectional Study at Dormaa Presbyterian Hospital, Ghana.采用血脂谱指标算法评估新诊断 2 型糖尿病患者的血脂异常:加纳多马阿长老会医院的一项横断面研究。
Medicina (Kaunas). 2019 Jul 21;55(7):392. doi: 10.3390/medicina55070392.
3
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.土耳其成年人血脂异常及相关危险因素的患病率:特拉布宗血脂研究
Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12.
4
Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.埃塞俄比亚北谢瓦接受联合抗逆转录病毒治疗的艾滋病毒感染患者血脂异常的患病率。
PLoS One. 2021 Apr 27;16(4):e0250328. doi: 10.1371/journal.pone.0250328. eCollection 2021.
5
Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities.南非合并症成年人血脂异常的流行率、模式和决定因素。
Sci Rep. 2022 Jan 10;12(1):337. doi: 10.1038/s41598-021-04150-6.
6
A systematic review and meta-analysis of the prevalence of dyslipidaemia among adults in Malaysia.马来西亚成年人血脂异常患病率的系统评价和荟萃分析。
Sci Rep. 2023 Jul 7;13(1):11036. doi: 10.1038/s41598-023-38275-7.
7
[Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].[吉林省社区糖尿病患者血脂异常情况分析]
Wei Sheng Yan Jiu. 2014 Sep;43(5):743-8.
8
High prevalence of dyslipidaemia among persons with diabetes mellitus and hypertension at a tertiary hospital in Blantyre, Malawi.马拉维布兰太尔一家三级医院中糖尿病和高血压患者中血脂异常的高发率。
BMC Cardiovasc Disord. 2022 Dec 22;22(1):557. doi: 10.1186/s12872-022-03011-y.
9
The burden of dyslipidaemia and factors associated with lipid levels among adults in rural northern Ghana: An AWI-Gen sub-study.加纳北部农村地区成年人血脂异常的负担及血脂水平相关因素:AWI-Gen 子研究。
PLoS One. 2018 Nov 28;13(11):e0206326. doi: 10.1371/journal.pone.0206326. eCollection 2018.
10
Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.刚果动脉高血压患者血清脂质和脂蛋白的相关因素
Cardiovasc J S Afr. 2005 Sep-Oct;16(5):249-55.

引用本文的文献

1
Risk Factors for Post-Stroke Seizures in a Tertiary Care Center: A Case-Control Study.三级医疗中心中风后癫痫发作的危险因素:一项病例对照研究。
Neuropsychiatr Dis Treat. 2024 Aug 26;20:1615-1628. doi: 10.2147/NDT.S473483. eCollection 2024.
2
Association between dyslipidaemia knowledge & lipid testing practice among adults, a community-based study.血脂知识与成年人血脂检测实践之间的关联:一项基于社区的研究。
PLoS One. 2024 Jul 30;19(7):e0306428. doi: 10.1371/journal.pone.0306428. eCollection 2024.
3
Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review.

本文引用的文献

1
The spectrum of the dyslipidemia in Colombia: The PURE study.哥伦比亚血脂异常谱:PURE 研究。
Int J Cardiol. 2019 Jun 1;284:111-117. doi: 10.1016/j.ijcard.2018.10.090. Epub 2018 Nov 5.
2
Hypertriglyceridaemia and risk of coronary artery disease.高甘油三酯血症与冠心病风险。
Nat Rev Cardiol. 2017 Jul;14(7):401-411. doi: 10.1038/nrcardio.2017.31. Epub 2017 Mar 16.
3
Prevalence of Dyslipidemia and Management in the Thai Population, National Health Examination Survey IV, 2009.2009年泰国全国健康检查调查IV:泰国人群血脂异常的患病率及管理情况
非诺贝特在亚洲人群血脂异常及相关合并症中的作用:一项叙述性综述。
Diabetes Metab J. 2024 Mar;48(2):184-195. doi: 10.4093/dmj.2023.0168. Epub 2024 Jan 26.
4
Age and Sex Differences in LDL Cholesterol Distribution in Adults in Malaysia: A Cross-Sectional Study (2010-2021).马来西亚成年人低密度脂蛋白胆固醇分布的年龄和性别差异:一项横断面研究(2010 - 2021年)
Int J Gen Med. 2023 Dec 12;16:5885-5888. doi: 10.2147/IJGM.S423091. eCollection 2023.
5
Prevalence of and factors associated with uncontrolled hypertension among patients with early chronic kidney disease attending tertiary hospitals in Dodoma, Tanzania: a cross-sectional study.坦桑尼亚多多马市三级医院就诊的早期慢性肾脏病患者中未控制高血压的患病率及相关因素:一项横断面研究。
BMJ Open. 2023 Dec 12;13(12):e074441. doi: 10.1136/bmjopen-2023-074441.
6
Role of community pharmacists in cardiovascular diseases-related health promotion and dyslipidemia management in Malaysia: A nationwide cross-sectional study.马来西亚社区药师在心血管疾病相关健康促进和血脂异常管理中的作用:一项全国性的横断面研究。
PLoS One. 2023 Sep 28;18(9):e0290883. doi: 10.1371/journal.pone.0290883. eCollection 2023.
7
Safety and efficacy of oil palm phenolic supplementation in improving lipid profile among hyperlipidemic adults: a phase 2, randomized, double-blind, placebo-controlled clinical trial.补充油棕酚对改善高脂血症成年人血脂水平的安全性和有效性:一项2期随机双盲安慰剂对照临床试验
Front Pharmacol. 2023 Jul 7;14:1190663. doi: 10.3389/fphar.2023.1190663. eCollection 2023.
8
A systematic review and meta-analysis of the prevalence of dyslipidaemia among adults in Malaysia.马来西亚成年人血脂异常患病率的系统评价和荟萃分析。
Sci Rep. 2023 Jul 7;13(1):11036. doi: 10.1038/s41598-023-38275-7.
9
Hypercholesterolemia in the Malaysian Cohort Participants: Genetic and Non-Genetic Risk Factors.马来西亚队列参与者的高胆固醇血症:遗传和非遗传风险因素。
Genes (Basel). 2023 Mar 15;14(3):721. doi: 10.3390/genes14030721.
10
Current Insights on Dyslipidaemia Management for Prevention of Atherosclerotic Cardiovascular Disease: A Malaysian Perspective.马来西亚视角:血脂异常管理预防动脉粥样硬化性心血管疾病的当前见解
Malays J Med Sci. 2023 Feb;30(1):67-81. doi: 10.21315/mjms2023.30.1.6. Epub 2023 Feb 28.
J Lipids. 2014;2014:249584. doi: 10.1155/2014/249584. Epub 2014 Mar 30.
4
Lipid profile parameters in Malaysian dyslipidemic patients.马来西亚血脂异常患者的血脂谱参数。
Kobe J Med Sci. 2011 Dec 15;57(2):E38-48.
5
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.富含甘油三酯的脂蛋白和心血管疾病高危患者的高密度脂蛋白胆固醇:管理的证据和指导。
Eur Heart J. 2011 Jun;32(11):1345-61. doi: 10.1093/eurheartj/ehr112. Epub 2011 Apr 29.
6
High prevalence of low HDL-c in the Philippines compared to the US: population differences in associations with diet and BMI.与美国相比,菲律宾高密度脂蛋白胆固醇(HDL-c)水平低的患病率较高:饮食和体重指数关联方面的人群差异。
Asia Pac J Clin Nutr. 2010;19(1):57-67.
7
Major lipids, apolipoproteins, and risk of vascular disease.主要脂质、载脂蛋白与血管疾病风险
JAMA. 2009 Nov 11;302(18):1993-2000. doi: 10.1001/jama.2009.1619.
8
Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.非高密度脂蛋白胆固醇降低与冠心病风险关系的荟萃分析
J Am Coll Cardiol. 2009 Jan 27;53(4):316-22. doi: 10.1016/j.jacc.2008.10.024.
9
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.残余风险降低倡议:呼吁采取行动降低血脂异常患者的残余血管风险。
Diab Vasc Dis Res. 2008 Nov;5(4):319-35. doi: 10.3132/dvdr.2008.046.
10
Lipid disorders among male factory shift workers in Kota Bharu, Kelantan.马来西亚吉兰丹州哥打巴鲁男性工厂轮班工人的血脂异常情况。
Med J Malaysia. 2007 Jun;62(2):134-8.